GLP-1 Coverage Cost-benefit Analysis
admin_hr&p2026-05-04T19:50:37+00:00GLP-1 Coverage Cost-benefit Analysis Over the past several years, glucagon-like peptide-1 (GLP-1) medications—such as Wegovy and Zepbound—have reshaped metabolic care. These drugs were originally developed for Type 2 diabetes, but now, when paired with diet and exercise, they are widely used for weight management, generating both curiosity and concern among employers and plan sponsors. [...]









